PL438609A1 - Composition containing a mixture of extracts from Vitis vinifera and Vaccinium angustifolium and probiotics to improve cognitive functions - Google Patents

Composition containing a mixture of extracts from Vitis vinifera and Vaccinium angustifolium and probiotics to improve cognitive functions

Info

Publication number
PL438609A1
PL438609A1 PL438609A PL43860921A PL438609A1 PL 438609 A1 PL438609 A1 PL 438609A1 PL 438609 A PL438609 A PL 438609A PL 43860921 A PL43860921 A PL 43860921A PL 438609 A1 PL438609 A1 PL 438609A1
Authority
PL
Poland
Prior art keywords
mixture
extracts
composition containing
probiotics
vitis vinifera
Prior art date
Application number
PL438609A
Other languages
Polish (pl)
Inventor
David Gaudout
Stéphane REY
Benoît LEMAIRE
Séverine DUBREUIL
Camille POUCHIEU
Original Assignee
Activ'inside
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activ'inside filed Critical Activ'inside
Publication of PL438609A1 publication Critical patent/PL438609A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Niniejszy wynalazek dotyczy kompozycji odżywczej lub farmaceutycznej zawierającej co najmniej jedną mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz co najmniej jedną bakterię probiotyczną i/lub drożdże probiotyczne. Taka kompozycja jest przeznaczona do stosowania jako produkt odżywczy lub lek w celu poprawy funkcji poznawczych u ludzi lub zwierząt.The present invention relates to a nutritional or pharmaceutical composition containing at least one mixture of Vitis vinifera and Vaccinium angustifolium extracts and at least one probiotic bacterium and / or probiotic yeast. Such a composition is intended for use as a nutritional product or medicament for the purpose of improving cognition in humans or animals.

PL438609A 2020-07-24 2021-07-26 Composition containing a mixture of extracts from Vitis vinifera and Vaccinium angustifolium and probiotics to improve cognitive functions PL438609A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR2007796A FR3112686B3 (en) 2020-07-24 2020-07-24 Composition comprising a mixture of Vitis vinifera and Vaccinium angustifolium extracts and probiotics to improve cognitive functions

Publications (1)

Publication Number Publication Date
PL438609A1 true PL438609A1 (en) 2022-01-31

Family

ID=78032387

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438609A PL438609A1 (en) 2020-07-24 2021-07-26 Composition containing a mixture of extracts from Vitis vinifera and Vaccinium angustifolium and probiotics to improve cognitive functions

Country Status (5)

Country Link
AU (1) AU2021107611A4 (en)
DK (1) DK202100060U3 (en)
FR (1) FR3112686B3 (en)
PL (1) PL438609A1 (en)
WO (1) WO2022018281A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3132221A1 (en) * 2022-01-28 2023-08-04 Activ'inside Use of a mixture of flavanols to increase the concentration of the active form of vitamin D, calcitriol.
CN115300532B (en) * 2022-09-20 2023-10-20 中加健康工程研究院(合肥)有限公司 Probiotic agent with Alzheimer disease cognitive ability improving function and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899768B1 (en) * 2006-04-14 2008-06-20 Juva Sante Soc Par Actions Sim ANTIOXIDANT FOOD SUPPLEMENT COMPRISING OLIGOPROANTHOCYANIDES, GAMMA-TOCOPHEROL, CATECHINS AND BIFLAVANES, CARNOSIC ACID AND CARNOSOL
EP2710901A1 (en) * 2012-09-20 2014-03-26 Symrise AG Dietary supplement compositions
FR3042712B1 (en) 2015-10-27 2019-05-03 Activ'inside SPECIAL NUTRITIONAL OR THERAPEUTIC AGENT COMPRISING A MIXTURE OF GRAPE AND BLUEBERRY
FR3042713B1 (en) * 2015-10-27 2019-10-11 Specialites Pet Food EFFICIENT ANTIOXIDANT COMPOSITION FROM A SYNERGISTIC VIEWPOINT FOR PETS
US11122832B2 (en) * 2016-03-07 2021-09-21 Nature's Sunshine Products, Inc. Methods and compositions to improve weight loss and cardiometabolic health beyond diet and excercise
CN107334025A (en) * 2017-08-08 2017-11-10 安徽永骏生物科技有限公司 A kind of blueberry fermented beverage
FR3088540B1 (en) * 2018-11-21 2023-05-12 Activinside SINGLE USE OF A COMPOSITION comprising a SPECIFIC blend of GRAPE EXTRACT AND BLUEBERRY EXTRACT

Also Published As

Publication number Publication date
WO2022018281A3 (en) 2022-03-10
AU2021107611A4 (en) 2022-01-06
FR3112686B3 (en) 2022-07-29
WO2022018281A2 (en) 2022-01-27
FR3112686A3 (en) 2022-01-28
DK202100060U3 (en) 2021-10-26

Similar Documents

Publication Publication Date Title
PL438609A1 (en) Composition containing a mixture of extracts from Vitis vinifera and Vaccinium angustifolium and probiotics to improve cognitive functions
BR112018005195A2 (en) lactobacillus plantarum lc27, pharmaceutical composition for the prevention or treatment of one or more diseases, food composition for the prevention or treatment of one or more diseases, method of prevention or treatment of one or more diseases, and use of a composition comprising lactobacillus plantarum lc27
BR112018015097A2 (en) composition and reactors
RS52833B (en) Oil composition for the preparation of oil containing food products
BR112019001984A2 (en) lactic acid bacteria and their use for the prevention, inhibition and / or reduction of bacterial biofilm formation
CL2018002148A1 (en) Use of bacterial strains belonging to the species lactobacillus kefiri in pediatrics to generate and / or maintain a state of homeostasis.
MX2021009443A (en) Compositions containing bacillaene producing bacteria or preparations thereof.
DE602004032502D1 (en) Treatment of cancer with natural plant products, essential oils or ingredients of Pistazia species
WO2019022602A8 (en) Pharmaceutical composition for use in the treatment or prevention of vitamin deficiency and mineral deficiency in patients who have been subjected to gastric sleeve surgery
BR112022025078A2 (en) AGENTS FOR ENHANCEMENT AND MAINTENANCE OF COGNITIVE FUNCTION AND HIPPOCAMPAL FUNCTION, FOOD OR BEVERAGES FOR ENHANCEMENT AND MAINTENANCE OF COGNITIVE FUNCTION AND HIPPOCAMPAL FUNCTION, AND, USE OF ONE OR BOTH OF BIFIDOBACTERIUM BREVE FERM BP-11175 AND A CULTURE OF BIFIDOBACTERIUM BREVE FERM BP-11175
PL433015A1 (en) Turmeric extract formulation containing curcuminoids, method of its preparation, beverage, beverage concentrate, dietary supplement, pharmaceutical composition containing the formulation, and use of the formulation in dietary supplements and pharmaceutical products activating acetaldehyde metabolism
MX2023009007A (en) Gitr antagonists and methods of using the same.
PL438420A1 (en) Use of cannabinoids as antioxidants acting as stabilizers to maintain the appropriate quality, properties and durability of food products (food), medicinal products, medical devices and cosmetics
PL422140A1 (en) Application of totarol and the totarol-containing pharmaceutical composition
BR112018071493A2 (en) uses of linoleic acid (la) and alpha linolenic acid (ala) in the manufacture of nutritional composition, nutritional composition, method for preventing decline in induced cognitive functioning, and method for preventing reduction in early stress induced neurogenesis
WO2021159068A8 (en) Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
PL416198A1 (en) Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application
TR2024002589A2 (en) Banana Cold Milk and Production Method
PL419333A1 (en) New Bifidobacterium animalis AMT30 bacterial strain and the composition containing the Bifidobacterium animalis AMT30 strain
PL437487A1 (en) Pharmaceutical composition and its antiviral application
PL433819A1 (en) Composition of bacteria with probiotic properties
PL438421A1 (en) Use of cannabinoids as antioxidants acting as stabilizers to maintain the appropriate quality, properties and durability of food products (food), medicinal products, medical devices and cosmetics
PL425240A1 (en) Application of 7-aminoflavone
PL438243A1 (en) Use of CBD and THC and other cannabinoids as antioxidants acting as stabilisers to maintain the quality, properties and shelf life of food products (food, including food supplements and foodstuffs for particular nutritional uses), medicinal products, medical devices and cosmetics
PL433077A1 (en) Bacteriophage strain and use of the bacteriophage strain to combat Salmonella enterica